Cover Image

WT1 together with RUNX1::RUNX1T1 targets DUSP6 to dampen ERK activity in acute myeloid leukaemia

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Nan Xu, Feng‐Ting Dao, Zong‐Yan Shi, Kai Sun, Ya‐Zhen Qin
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core‐binding factor‐acute myeloid leukaemia
by: Siyang Wang, et al.
Published: (2024)

Preclinical activity of resazurin in acute myeloid leukaemia
by: Trung Quang Ha, et al.
Published: (2024)

Pregnancy and delivery outcomes in individuals with RUNX1‐Familial Platelet Disorder
by: Natalie T. Deuitch, et al.
Published: (2025)

CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia
by: Alexandra Dreyzin, et al.
Published: (2025)

ZIP10 as a potential therapeutic target in acute myeloid leukaemia
by: Benjamin Rolles, et al.
Published: (2025)

Sweet's syndrome in acute myeloid leukaemia
by: Hsu T. Mon, et al.
Published: (2026)

Immunophenotypic clustering in paediatric acute myeloid leukaemia
by: Hui Liu, et al.
Published: (2024)

Oral decitabine–cedazuridine in acute myeloid leukaemia
by: Ian M. Bouligny, et al.
Published: (2024)

The Menin story in acute myeloid leukaemia—The road to success
by: Michael W. M. Kühn, et al.
Published: (2024)

Leucostasis‐induced limb ischaemia in acute myeloid leukaemia
by: Yorick Sandberg, et al.
Published: (2025)

Masked critical thrombocytopenia in hypercellular acute myeloid leukaemia
by: Wing Kit Lam, et al.
Published: (2026)

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm
by: Stéphane De Botton, et al.
Published: (2024)

Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemia
by: Li‐Xin Wu, et al.
Published: (2025)

Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights
by: Boaz Nachmias, et al.
Published: (2024)

Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications
by: Sean Harrop, et al.
Published: (2024)

Selective small molecule targeting of KDM4 as a therapeutic strategy to reduce proliferation of acute myeloid leukaemia
by: Laura Monaghan, et al.
Published: (2026)

Corrigendum to “Histone demethylase PHF8 facilitates the development of chronic myeloid leukaemia by directly targeting BCR::ABL1 ”
Published: (2024)

Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis
by: Huimin Jin, et al.
Published: (2025)

Two novel families with RUNX1 variants indicate glycine 168 as a new mutational hotspot: Implications for FPD/AML diagnosis
by: Laureano J. Kamiya, et al.
Published: (2024)

Measurable residual disease‐guided therapy in acute myeloid leukaemia: Practical insights
by: Boaz Nachmias, et al.
Published: (2025)

Decoding the molecular drivers of TP53 ‐mutant acute myeloid leukaemia: Clinical implications and prognostic insights
by: Lin‐Ya Wang, et al.
Published: (2025)

Immune‐deficient MISTRG mice support expansion of leukaemia‐initiating cells in xenograft models of paediatric acute myeloid leukaemia
by: Patrick Connerty, et al.
Published: (2025)

Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high‐risk KMT2A ‐rearranged acute myeloid leukaemia
by: Arundhati Chavan, et al.
Published: (2025)

MN1::ETV6‐positive de novo T‐cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report
by: Xiang Zhang, et al.
Published: (2024)

Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
by: Peiqi Liang, et al.
Published: (2024)

A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction
by: Cesar Alexander Ortiz Rojas, et al.
Published: (2024)

Azacitidine–venetoclax in unfit acute myeloid leukaemia: One size does not fit all
by: Felicetto Ferrara
Published: (2026)

The heart of VIALE‐A: Cardiac complications of hypomethylating agents and venetoclax in acute myeloid leukaemia
by: Shyam A. Patel
Published: (2024)

Promoter‐centred chromatin interactions associated with EVI1 expression in EVI1 +3q− myeloid leukaemia cells
by: Han Leng Ng, et al.
Published: (2024)

The Mozart effect in chronic myeloid leukaemia
by: Jesper Stentoft
Published: (2024)

Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease
by: Wei‐Ying Jen, et al.
Published: (2024)

Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents
by: Isla M. Johnson, et al.
Published: (2024)

Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy
by: Takaaki Konuma, et al.
Published: (2025)

Single‐cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia
by: Yu Liu, et al.
Published: (2025)

POU6F2, a novel fusion partner of NUP98 in acute myeloid leukaemia: A case report
by: Yu Jeong Choi, et al.
Published: (2024)

Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia
by: Francesca A. M. Kinsella, et al.
Published: (2024)

Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO‐DBH AML study
by: Morten Krogh Herlin, et al.
Published: (2025)

An old leukaemia in young patients—Genetic characteristics of paediatric chronic myeloid leukaemia
by: Markus Metzler, et al.
Published: (2025)

Global spatiotemporal distribution characteristics and regional risk stratification model of acute myeloid leukaemia based on molecular genetics and cytogenetic features
by: Jilong Xiao, et al.
Published: (2025)

A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia
by: Thierry Soussi, et al.
Published: (2025)